Literature DB >> 6724267

Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.

H Fromm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724267

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  The effect of ursodeoxycholic acid in liver functional restoration of patients with obstructive jaundice after endoscopic treatment: a prospective, randomized, and controlled study.

Authors:  Enver Fekaj; Arben Gjata; Mehmet Maxhuni
Journal:  BMC Surg       Date:  2013-09-22       Impact factor: 2.102

2.  Optimum bile acid treatment for rapid gall stone dissolution.

Authors:  R P Jazrawi; M G Pigozzi; G Galatola; A Lanzini; T C Northfield
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

3.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

4.  Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex.

Authors:  Peng-Fei Yue; Wen-Jin Zhang; Hai-Long Yuan; Ming Yang; Wei-Feng Zhu; Pei-Lie Cai; Xiao-He Xiao
Journal:  AAPS PharmSciTech       Date:  2008-02-07       Impact factor: 3.246

5.  Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.

Authors:  R Roehrkasse; H Fromm; M Malavolti; A K Tunuguntla; S Ceryak
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

Review 6.  The effect of drugs on bile flow and composition. An overview.

Authors:  L Okolicsanyi; F Lirussi; M Strazzabosco; R M Jemmolo; R Orlando; G Nassuato; M Muraca; G Crepaldi
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.